Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Anderson

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|September 1, 2011
Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trialsJean Y Tang, Katrina M Spaunhurst, Rowan T Chlebowski, et al.
Cancer Letters|March 5, 2013
Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomasClaire M Mach, Jong Kim, Benjamin Soibam, et al.
Molecular Endocrinology (Baltimore, Md.)|March 29, 2016
Endometrial Expression of Steroidogenic Factor 1 Promotes Cystic Glandular MorphogenesisYasmin M Vasquez, San-Pin Wu, Matthew L Anderson, et al.
Gynecologic Oncology|November 20, 2018
Inversely and adaptively planned interstitial brachytherapy: A single implant approachAlexander N Hanania, Pamela Myers, Alison K Yoder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 27, 2013
Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal womenGeoffrey C Kabat, Matthew L Anderson, Moonseong Heo, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 15, 2022
FKBP51 Contributes to Uterine Leiomyoma Pathogenesis by Inducing Cell Proliferation and Extracellular Matrix DepositionErika P New, Nihan Semerci, Asli Ozmen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignanciesCarlos A Ramos, Neeharika Narala, Gayatri M Vyas, et al.
Frontiers in Surgery|November 29, 2023
Feasibility and safety of planned early discharge following laparotomy in gynecologic oncology with enhanced recovery protocol including opioid-sparing anesthesiaMichelle L Kuznicki, Maya Yasukawa, Adrianne R Mallen, et al.
Cancer Research|October 22, 2009
A role for BRCA1 in uterine leiomyosarcomaDeyin Xing, George Scangas, Mai Nitta, et al.
Molecular Endocrinology (Baltimore, Md.)|January 19, 2010
A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancerAnkur K Nagaraja, Chad J Creighton, Zhifeng Yu, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|September 1, 2011
Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trialsJean Y Tang, Katrina M Spaunhurst, Rowan T Chlebowski, et al.
Cancer Letters|March 5, 2013
Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomasClaire M Mach, Jong Kim, Benjamin Soibam, et al.
Molecular Endocrinology (Baltimore, Md.)|March 29, 2016
Endometrial Expression of Steroidogenic Factor 1 Promotes Cystic Glandular MorphogenesisYasmin M Vasquez, San-Pin Wu, Matthew L Anderson, et al.
Gynecologic Oncology|November 20, 2018
Inversely and adaptively planned interstitial brachytherapy: A single implant approachAlexander N Hanania, Pamela Myers, Alison K Yoder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 27, 2013
Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal womenGeoffrey C Kabat, Matthew L Anderson, Moonseong Heo, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 15, 2022
FKBP51 Contributes to Uterine Leiomyoma Pathogenesis by Inducing Cell Proliferation and Extracellular Matrix DepositionErika P New, Nihan Semerci, Asli Ozmen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignanciesCarlos A Ramos, Neeharika Narala, Gayatri M Vyas, et al.
Frontiers in Surgery|November 29, 2023
Feasibility and safety of planned early discharge following laparotomy in gynecologic oncology with enhanced recovery protocol including opioid-sparing anesthesiaMichelle L Kuznicki, Maya Yasukawa, Adrianne R Mallen, et al.
Cancer Research|October 22, 2009
A role for BRCA1 in uterine leiomyosarcomaDeyin Xing, George Scangas, Mai Nitta, et al.
Molecular Endocrinology (Baltimore, Md.)|January 19, 2010
A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancerAnkur K Nagaraja, Chad J Creighton, Zhifeng Yu, et al.
Pageof 9